Clinical Trial Update: Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an anxiety sensitivity-based intervention for co-occurring substance use disorders and anxiety has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Substance Use Disorder

Snippet

Sponsor: Hartford Hospital | Conditions: Other (or Unknown) Substance Use Disorders | Phase 2 | Status: COMPLETED